Fragment-based drug design and drug repositioning using multiple ligand simultaneous docking (MLSD): identifying celecoxib and template compounds as novel inhibitors of signal transducer and activator of transcription 3 (STAT3).
Development of a classification scheme for disease-related enzyme information.
Structural diversity of biologically interesting datasets: a scaffold analysis approach.
A retrosynthetic biology approach to metabolic pathway design for therapeutic production.
Trends in the exploitation of novel drug targets.
The Structural Biology Knowledgebase: a portal to protein structures, sequences, functions, and methods.
ChemMine tools: an online service for analyzing and clustering small molecules.
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome.
Predicting adverse drug reactions using publicly available PubChem BioAssay data.
Structural effects and translocation of doxorubicin in a DPPC/Chol bilayer: the role of cholesterol.